Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
AMYPAD DMPS enrols its first research participant
AMYPAD DMPS enrols its first research participant 04 May 2018 The members of the AMYPAD initiative proudly announced the recruitment of its first research participant today......
AMYPAD is glad to be featured in the journal of Alzheimer's Disease
AMYPAD is glad to be featured in the journal of Alzheimer's Disease 01 May 2018 The IOS Press announced that 2018 marks the 20th anniversary of the Journal of Alzheimer’s Disease with a milestone issue covering 20 years of Alzheimer's research......
Open Lecture on Biomarkers and Disease Modeling in Alzheimer’s disease
Open Lecture on Biomarkers and Disease Modeling in Alzheimer’s disease 18 Apr 2018 The AMYPAD team took the opportunity to invite two prestigious guest speakers and host an Open Lecture to present......
"At this moment, there is a massive effort to better understand the natural history of Alzheimer’s Disease (AD), as well to improve its management. These efforts wish to increase the chances of success for future clinical trials by allowing them to target populations at the early stages of the disease, when the damage could still be reversed. AMYPAD comes to provide valuable insight on a fundamental piece of the AD puzzle: the accumulation of β-amyloid plaques. We will be doing so by determining the role and value of amyloid imaging in disease diagnosis, prognosis, and potential for treatment monitoring - which will be a crucial step forward in the global fight against AD.” Frederik Barkhof
Frederik Barkhof

AMYPAD Project Coordinator and Professor of Neuroradiology at VU University Medical Centre, Amsterdam and at University College London.